Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Ulcerative Colitis Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.6 Billion by the end of ... Read More
-
Spinal Fusion Devices
... at a CAGR of 3.4% over the analysis period 2024-2030. Thoracolumbar Devices, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$5.8 Billion by the end of ... Read More
-
Airway Clearance Systems
... at a CAGR of 4.7% over the analysis period 2024-2030. Positive Expiratory Pressure (PEP) Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$396.2 Million by ... Read More
-
Asthma Therapeutics
... CAGR of 2.3% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.7 Billion by the end of the analysis ... Read More
-
Benign Prostatic Hyperplasia Devices
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. TURP Procedure, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$389.8 Million by the ... Read More
-
Nutrition for Aging News
... needs of older adults. With a focus on sustaining energy, enhancing mental clarity, and maintaining a healthy weight, the newsletter explores how targeted diets can support overall well-being. It also provides valuable information on addressing ... Read More
-
Metabolic Health
... cutting-edge products designed to optimize energy levels and support a healthier lifestyle. It will include expert insights on how diet, exercise, and sleep impact metabolic health to the newest research on food supplements and interventions. Read More
-
Mindfulness and Stress Reduction
... reduce anxiety, combat negativity, and support mental well-being. With a focus on practical tools such as meditation apps and guided exercises, Mindfulness and Stress Reduction offers simple yet effective approaches to feeling more grounded, improving ... Read More
-
Brain Tumor Diagnosis and Treatment
... Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Primary Brain Tumor, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 ... Read More
-
Family Planning Centers
... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More
-
Anti-Allergy Drugs
... CAGR of 7.1% over the analysis period 2024-2030. Pharmacies End-Use, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$35.4 Billion by the end of the analysis ... Read More
-
Angiography Devices
... CAGR of 3.9% over the analysis period 2024-2030. Angiography Systems, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.8 Billion by the end of the analysis ... Read More
-
Anxiolytics
... 4.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$259.8 Million While China is Forecast to Grow at 7.1% CAGR The Anxiolytics market in the U.S. is estimated at US$259.8 Million in ... Read More
-
Hematology Testing Products
... at a CAGR of 4.4% over the analysis period 2024-2030. Hematology Testing Instruments & Software, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$9.8 Billion by ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Cognitive Assessment and Training
... 2030, growing at a CAGR of 26.9% over the analysis period 2024-2030. Cognitive Assessment and Training Solutions, one of the segments analyzed in the report, is expected to record a 24.9% CAGR and reach US$17.4 ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Antibiotics
... 3.1% over the analysis period 2024-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth in ... Read More
-
Prostate Cancer Therapeutics
... at a CAGR of 6.6% over the analysis period 2024-2030. Hormone Therapy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$21.0 Billion by the end of ... Read More
-
Cosmetic Procedures and Products
... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Facial Injectables, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.1 Billion by the ... Read More
-
Cardiovascular Drugs
... CAGR of 3.4% over the analysis period 2024-2030. Anticoagulants, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$57.7 Billion by the end of the analysis period. ... Read More
-
Nephrology And Urology Devices
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Dialysis Devices, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$28.9 Billion by the ... Read More
-
Retinal Laser Equipment
... at a CAGR of 7.1% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$693.0 Million by the end of ... Read More
-
Knee Braces
... CAGR of 5.2% over the analysis period 2024-2030. Functional Knee Braces, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$875.4 Million by the end of the ... Read More
-
Gastrointestinal Videoscopes
... CAGR of 6.4% over the analysis period 2024-2030. Hospitals Application, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$5.3 Billion by the end of the analysis ... Read More
Research Assistance
